Boiron 

€27.10
84
+€0.10+0.37% Monday 06:01

Statistics

Day High
27.1
Day Low
27.1
52W High
31.35
52W Low
21.3
Volume
0
Avg. Volume
0
Mkt Cap
475.47M
P/E Ratio
-
Dividend Yield
4.98%
Dividend
1.35

Upcoming

Dividends

4.98%Dividend Yield
Jun 26
€1.35
Jun 25
€1.20
Jun 24
€1.35
Oct 23
€10.36
Jun 23
€1.10
10Y Growth
-1.05%
5Y Growth
7.28%
3Y Growth
7.06%
1Y Growth
12.5%

Financials

6.51%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
501.11MRevenue
32.64MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BON.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Reckitt Benckiser Group
RBGLY
Mkt Cap43.06B
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products, competing in the homeopathic and natural health sector similar to Boiron.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. is a global pharmaceutical corporation which, through its range of healthcare products and medications, competes in the broader pharmaceutical and healthcare market against companies like Boiron.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson is a multinational corporation that produces pharmaceuticals, medical devices, and consumer packaged goods, directly competing with Boiron in the healthcare and wellness sectors.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline plc is a global healthcare company that researches and develops a wide range of medicines and healthcare products, competing with Boiron in the pharmaceutical and healthcare market.
Novartis
NVS
Mkt Cap293.94B
Novartis AG focuses on the discovery, development, and marketing of healthcare products, directly competing with Boiron in the pharmaceutical and health products sector.
Bayer
BAYRY
Mkt Cap56.12B
Bayer AG operates as a life science company with activities in pharmaceuticals, consumer health, and crop science, competing with Boiron in the health and wellness market.
Sanofi
SNY
Mkt Cap104.13B
Sanofi is a global healthcare leader that researches, develops, and distributes therapeutic solutions, competing with Boiron in the healthcare and pharmaceutical sectors.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals and vaccines, competing with Boiron in the broader healthcare and pharmaceutical market.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Boiron in the healthcare and pharmaceutical sectors.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, competing with Boiron in the pharmaceutical and healthcare industry.

About

Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North America, and numerous international territories. The company's offerings comprise a diverse array of homeopathic products, including both non-proprietary and branded formulations. Notable examples from its brand portfolio target specific health concerns: Oscillococcinum is formulated to alleviate symptoms associated with influenza, such as fever, chills, headaches, and general body aches. Stodal and Stodaline are designed for the symptomatic relief of coughs. Arnigel provides topical support for minor, non-open traumatic injuries. Camilia is specifically developed to soothe teething discomfort in infants. Sédatif PC addresses anxiety, emotional imbalances, and mild sleep disturbances. Coryzalia helps manage cold symptoms and rhinitis. Homéoptic offers relief for various types of eye irritation and discomfort in both adults and children. Homéovox is aimed at vocal disorders. Beyond its core homeopathic line, Boiron provides a range of supplementary health products. These include dietary supplements; the Dermoplasmine collection (available as stick, balm, and mousse) for dry lips and skin; Mag' Nuit, designed to aid sleep; Arnitrosium for joint pain; Castor Equi Boiron ointment to treat cracked skin; and Storinil, a syrup for cold treatment. Furthermore, the company produces herbal medicines, such as Canephron, which supports increased urine production and improved urinary elimination. Its product list also features moisturizing baby milk and a selection of medical devices, including COVID-19 self-tests and rapid antigenic tests. Boiron distributes its extensive product portfolio through a wide network, encompassing its own distribution centers, independent pharmacies, large pharmacy chains, wholesalers, grocery stores, specialized health food retailers, and online sales platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.
Show more...
CEO
Country
France
ISIN
FR0000061129

Listings

0 Comments

Share your thoughts

FAQ

What is Boiron stock price today?
The current price of BON.MU is €27.10 EUR — it has increased by +0.37% in the past 24 hours. Watch Boiron stock price performance more closely on the chart.
What is Boiron stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Boiron stocks are traded under the ticker BON.MU.
What is Boiron market cap?
Today Boiron has the market capitalization of 475.47M
What is Boiron revenue for the last year?
Boiron revenue for the last year amounts to 501.11M EUR.
What is Boiron net income for the last year?
BON.MU net income for the last year is 32.64M EUR.
Does Boiron pay dividends?
Yes, BON.MU dividends are paid annual. The last dividend per share was 1.35 EUR. As of today, Dividend Yield (FWD)% is 4.98%.
In which sector is Boiron located?
Boiron operates in the Materials sector.
When did Boiron complete a stock split?
Boiron has not had any recent stock splits.